Scientists hypothesize that women with PMDD are more vulnerable to certain neurotransmitters in the central nervous system. They believe ovarian function is negatively affected by serotonin and gamma-aminobutyric acid, GABA, during the luteal phase or latter half of a woman's cycle. Serotonin is a feel-good neurotransmitter and GABA is known for promoting relaxation. Research suggests that during this phase, ovarian steroids such as estrogen somehow disrupt the effects of these two chemicals, contributing to PMDD.

This site offers information designed for educational purposes only. You should not rely on any information on this site as a substitute for professional medical advice, diagnosis, treatment, or as a substitute for, professional counseling care, advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other healthcare professional.